The trial was stopped prematurely because of adverse events (hyperkalemia and hypotension).81 Therefore, ACE inhibitors should not be used concomitantly with ARBs and renin inhibitors because of the increased risks for hypotension, hyperkalemia, and renal dysfunction.82 The gene discussed is ACE; the disease is Hyperkalemia.